Shibuya Corporation

Basic Information

Stock Code
6340
Industry
Machinery
Category Detail
Manufacturing Machinery & Electrical Equipment
Prefecture
Ishikawa Prefecture
Establishment Year
June 1949
Listing Year
February 1982
Official Website
https://www.shibuya.co.jp/
TSE Information
TSE Information
Yahoo! Finance
Yahoo! Finance
Other Companies
WNI Weather, Kurosaki Harima, General Packer, Leon, Tokyo Jido Kikai Seisakusho

Overview

Shibuya Corporation is a machinery manufacturer established in 1949, holding the top domestic share primarily in bottling systems, and advancing cutting-edge technology development in the regenerative medicine field.

Current Situation

Shibuya Corporation achieved consolidated sales of approximately ¥115.4 billion and operating profit of approximately ¥13.4 billion in the fiscal year ending June 2024, holding about 60% domestic share in bottling machines. In addition to its mainstay packaging plant business, it operates in semiconductor manufacturing equipment and medical devices. In recent years, it has world-leading technological advancements in equipment development for regenerative medicine using iPS cells, promoting practical implementation of compact automatic cell culture systems and development of bio 3D printers. It is also expanding overseas, establishing a service base in Indonesia and targeting growth in emerging markets. It strengthens clean manufacturing through environmentally low-impact and aseptic filling technologies. Its medium-term management plan from 2025 to 2027 aims to expand in regenerative medicine and improve earnings through technological innovation. It has multiple factories in Ishikawa Prefecture and collaborates with group companies to offer diverse products and services.

Trivia

Interesting Facts

  • Holds approximately 60% share in domestic beverage bottling systems.
  • Developed the world's first fully automatic size-change F-CAM system in 1991.
  • World-first commercialization of aseptic culture devices used in iPS cell research.
  • Pioneer developer of laser-based athlete's foot treatment devices.
  • Practical implementation of regenerative medicine support technology using bio 3D printers.
  • Products registered as Ishikawa Monozukuri Industrial Heritage.
  • Holds about 20% market share in OEM production of medical artificial dialysis devices.
  • Signed industry-academia collaboration agreement with NITTE University in India.
  • Multiple factories rooted in the region, contributing to local economy.
  • Group consolidated sales surpassed ¥100 billion in 2019.

Hidden Connections

  • Leading the forefront of regenerative medicine through joint development with bio ventures.
  • Originator of multi-variety bottle-compatible bottling machines for major sake manufacturers.
  • Jointly developing cell culture devices with the National Institute of Advanced Industrial Science and Technology.
  • Entered bio field through partnership with Sanyo Electric Biomedica.
  • Company representative serves as chairman of Ishikawa Prefecture Iron and Machine Electric Association.
  • Accelerating international expansion with numerous overseas local subsidiaries in the group.
  • Laser marking technology for products has become the industry standard.
  • Twin-type sake bottle washing machine certified as Ishikawa Prefecture industrial heritage.

Future Outlook

Growth Drivers

  • Rapid growth in regenerative medicine-related equipment market
  • Increasing demand for beverage and pharmaceutical packaging in emerging markets
  • Growing needs for multi-variety adaptability leveraging advanced technology
  • Strengthened collaboration with cutting-edge biotech like iPS cells
  • Resilient supply chains domestically and internationally
  • Acceleration of technological innovation through industry-academia collaboration
  • Rising demand for low-environmental-impact products
  • Expansion of medical equipment market for aging society
  • Promotion of digitalization and automation technology adoption
  • Expanded utilization of global talent
  • Customization capabilities and rapid response systems
  • Further expansion of overseas local subsidiaries

Strategic Goals

  • Achieve 70% domestic share in bottling systems
  • Enter world's top 5 in regenerative medicine equipment
  • Over 40% sales ratio from emerging markets
  • Over 50% sales ratio of environmentally considerate products
  • 30% improvement in operational efficiency through internal DX
  • Over 20 industry-academia collaboration projects annually
  • Double the number of bases to strengthen Asia expansion
  • 30% reduction in group-wide CO2 emissions
  • Improved productivity through employee diversity
  • Increased patents in medical and bio fields

Business Segments

Packaging Equipment for Beverage and Food Manufacturers

Overview
Provides high-performance packaging equipment capable of multi-variety, small-lot production.
Competitiveness
Domestic top share in aseptic filling technology and multi-variety adaptability
Customers
  • Major beverage manufacturers
  • Small and medium-sized food processing companies
  • Sake and liquor manufacturers
  • Seasoning manufacturers
  • Pharmaceutical manufacturers
  • Cosmetics manufacturers
Products
  • Bottling devices
  • Aseptic filling machines
  • Labeling machines
  • Packaging systems
  • Robot transfer systems

Semiconductor and LCD Manufacturing Equipment Related

Overview
Supports improved manufacturing efficiency and quality assurance with high-precision machinery.
Competitiveness
High-quality products from fusion of precision processing and clean technology
Customers
  • Semiconductor manufacturers
  • LCD panel manufacturers
  • Inspection equipment manufacturers
Products
  • Manufacturing dicing equipment
  • Transfer and alignment equipment
  • Inspection robots

Medical Devices and Regenerative Medicine Equipment Business

Overview
Develops and provides high-value-added equipment specialized for advanced medical fields.
Competitiveness
World-first development technology for iPS cell culture devices
Customers
  • Hospitals and medical institutions
  • Regenerative medicine ventures
  • Research institutions
  • Pharmaceutical companies
Products
  • Cell culture devices
  • OEM artificial dialysis equipment
  • Therapeutic laser equipment
  • Bio 3D printers

Robot System Integration Solutions

Overview
Proposes robots and control systems to accelerate factory automation.
Competitiveness
Fusion of multi-variety adaptability and precise control technology
Customers
  • Various manufacturing companies
  • Logistics companies
  • Major packaging companies
Products
  • Automated transfer robots
  • Manufacturing line integrated control systems

Equipment Maintenance and Service

Overview
Provides comprehensive maintenance support to improve product uptime.
Competitiveness
Regionally close support system with high technical capabilities
Customers
  • Users of our and group products
  • Overseas base companies
  • Emerging market companies
Products
  • Regular maintenance
  • Troubleshooting
  • Technical support and training services

Overseas Market Business Expansion Support

Overview
Implements various support to promote business expansion in emerging countries.
Competitiveness
Local adaptation business model leveraging industry-academia collaboration
Customers
  • Southeast Asian food processing companies
  • Indian manufacturing companies
  • Overseas medical equipment-related companies
Products
  • Local sales and service bases
  • Technology transfer support
  • Industry-academia collaboration projects

Competitive Advantage

Strengths

  • Domestic top share in bottling machines
  • Advanced aseptic filling technology
  • Cutting-edge technology in regenerative medicine equipment
  • Manufacturing equipment adaptable to multiple varieties
  • Long history and proven reliability
  • Diversified business portfolio
  • Strong domestic and international sales network
  • Active promotion of industry-academia collaboration
  • Advanced automation technology and precision processing
  • Environmentally considerate product development
  • OEM track record in medical field
  • Integrated provision of filling and packaging systems
  • Advanced robot control technology
  • Strengthened collaboration with local community
  • Growth strategy in overseas markets

Competitive Advantages

  • Dominant market position with over 60% domestic share in bottling equipment
  • World-unique development technology for iPS cell culture devices
  • Superior flexible manufacturing line design for multi-variety production
  • Differentiation through advanced laser marking technology
  • High reputation and stable supply system for medical aseptic filling machines
  • Wide product lineup from industrial machinery to medical devices
  • Accumulated know-how in robot system control over many years
  • Rapid response in overseas emerging markets via local subsidiaries
  • Technological superiority from international collaborative research on cell culture equipment
  • Customization capabilities and comprehensive after-sales service
  • Proven flexibility for small and medium-sized sake manufacturers
  • Portfolio of patented technologies with unique aseptic filling know-how
  • Risk diversification and quality stability through multi-site production
  • Ongoing R&D investment driving technological innovation
  • New business creation capabilities based on regional industry-academia collaboration

Threats

  • Intensifying low-price competition from emerging market companies
  • Business cycle risks in semiconductor industry
  • Impacts from regulatory changes in regenerative medicine market
  • Challenges in technology succession due to talent acquisition difficulties
  • Political risks and exchange rate fluctuations in overseas markets
  • Obsolescence of existing technologies due to emergence of new technologies
  • Rising manufacturing costs from stricter environmental regulations
  • Supply chain disruptions from COVID-19 and similar events
  • Delays in development to meet diversifying customer needs
  • Market reorganization from competitors' M&A
  • Intellectual property infringement risks
  • Brand image decline from quality incidents

Innovations

2024: Launch of Automated Cell Culture System for Autologous Cell Banks

Overview
New commercialization and sales rollout of automated cell culture devices for regenerative medicine.
Impact
Leading expansion in regenerative medicine equipment market

2024: Establishment of New Service Base in Indonesia

Overview
Opened service base to strengthen service structure in Southeast Asian market.
Impact
Contributes to faster local customer response and market expansion

2023: Joint Development of Next-Generation CAR-T Automated Manufacturing System

Overview
Joint development with Noile Immune Biotech of automated manufacturing system for next-generation CAR-T cells targeting solid tumors.
Impact
Expected market rollout as innovative cell therapy equipment

2022: Development and Practical Implementation of Bio 3D Printer Regenova

Overview
Productized world's first 3D cell layering technology printer.
Impact
Contributes to expansion of regenerative medicine research and applications

2021: Improvement of Multi-variety Bottling Automatic Size Change System

Overview
Significantly enhanced performance of filling devices capable of fully automatic adaptation to different bottle types.
Impact
Achieved 20% improvement in customer production efficiency

Sustainability

  • Food loss reduction through aseptic filling technology
  • Promotion of energy-saving in products
  • Improved recycling rate of factory waste
  • Environmental conservation through collaboration with local industries
  • Promotion of social implementation of regenerative medicine technology